N07C Antivertigo preparations
ATC group of level 3 – pharmacological subgroup · in plain English: medicines for addiction and other diseases of the nervous system
This site has the patient leaflet or the SPC of 20 medicines in this group and its subgroups.
- 2 without a prescription (P or GSL)
- 12 prescription only (POM)
- 6 no longer supplied or not available
Place in the ATC classification
- N Nervous system drugs 4,479 medicines
- N07 Other nervous system drugs 248 medicines
-
N07C Antivertigo preparations 20 medicines
- N07CA Antivertigo preparations 20 medicines
-
N07C Antivertigo preparations 20 medicines
- N07 Other nervous system drugs 248 medicines
Active substances in the group
- Betahistine 14 medicines
- Cinnarizine 6 medicines
- Dimenhydrinate 3 medicines
Medicines in the group and its subgroups
Other groups of the same level
- N07A Parasympathomimetics 12 medicines
- N07B Drugs used in addictive disorders 173 medicines
- N07X Other nervous system drugs 40 medicines
Other names of the ATC group
- Czech: N07C Antivertiginóza
- French: N07C médicaments antivertigineux
- German: N07C Antivertiginosa
- Spanish: N07C Medicamentos contra el vertigo
- German: N07C ANTIVERTIGINOSA
- Italian: N07C Preparati antivertigine
- Polish: N07C Przeciw zawrotom głowy
- Turkish: N07C ANTİVERTİGO HAZIRLIKLARI
- Portuguese (Brazil): N07C FÁRMACOS ANTI-VERTIGINOSOS
- Slovak: N07C Antivertiginóza
- German (Switzerland): N07C Antivertiginosa
- French (Switzerland): N07C Médicaments antivertigineux
- Italian (Switzerland): N07C Preparati antivertigine
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group N07C
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
